Linda Boxer, MD, PhD

Hematologist

Multiple myeloma specialist

Hematology Program

  • 875 Blake Wilbur Drive
  • Palo Alto, CA 94304
  • Phone: 650-498-6000
Learn More About the Clinic Getting Here Make An Appointment

Professional Education

Fellowship: Stanford University School of Medicine (1990) CA

Fellowship: Stanford University School of Medicine (1989) CA

Residency: Stanford University School of Medicine (1984) CA

Internship: Stanford University School of Medicine (1982) CA

Board Certification: Medical Oncology, American Board of Internal Medicine (1987)

Board Certification: Internal Medicine, American Board of Internal Medicine (1984)

Medical Education: Stanford University School of Medicine (1981) CA

MD, Stanford University, Medicine (1981)

PhD, Stanford University, Biophysics (1981)

Administrative Appointments

Chief, Division of Hematology, Stanford University School of Medicine, 2004

Clinical interpretation and implications of whole-genome sequencing.
Dewey, F. E., Grove, M. E., Pan, C., Goldstein, B. A., Bernstein, J. A., & Quertermous, T. (2014). Clinical interpretation and implications of whole-genome sequencing. JAMA : the journal of the American Medical Association, 311(10), 1035-1045.

The immunoglobulin heavy chain gene 3 ' enhancers induce Bcl2 deregulation and lymphomagenesis in murine B cells
Xiang, H., Noonan, E. J., Wang, J., Duan, H., Ma, L., & Boxer, L. M. (2011). The immunoglobulin heavy chain gene 3 ' enhancers induce Bcl2 deregulation and lymphomagenesis in murine B cells. LEUKEMIA, 25(9), 1484-1493.

Functional long-range interactions of the IgH 3 ' enhancers with the bcl-2 promoter region in t(14;18) lymphoma cells
Duan, H., Xiang, H., Ma, L., & Boxer, L. M. (2008). Functional long-range interactions of the IgH 3 ' enhancers with the bcl-2 promoter region in t(14;18) lymphoma cells. ONCOGENE, 27(53), 6720-6728.

Protein/DNA arrays identify nitric oxide-regulated cis-element and trans-factor activities some of which govern neuroblastoma cell viability
Dhakshinamoorthy, S., Sridharan, S. R., Li, L., Ng, P. Y., Boxer, L. M., & Porter, A. G. (2007). Protein/DNA arrays identify nitric oxide-regulated cis-element and trans-factor activities some of which govern neuroblastoma cell viability. NUCLEIC ACIDS RESEARCH, 35(16), 5439-5451.

The immunoglobulin heavy-chain gene 3 ' enhancers deregulate bcl-2 promoter usage in t(14;18) lymphoma cells
Duan, H., Heckman, C. A., & Boxer, L. M. (2007). The immunoglobulin heavy-chain gene 3 ' enhancers deregulate bcl-2 promoter usage in t(14;18) lymphoma cells. ONCOGENE, 26(18), 2635-2641.

Activation of the c-myc p1 promoter in Burkitt's lymphoma by the hs3 immunoglobulin heavy-chain gene enhancer
Hu, H.-M., Kanda, K., Zhang, L., & Boxer, L. M. (2007). Activation of the c-myc p1 promoter in Burkitt's lymphoma by the hs3 immunoglobulin heavy-chain gene enhancer. LEUKEMIA, 21(4), 747-753.

Artificial zinc(II) complexes regulate cell cycle and apoptosis-related genes in tumor cell lines
Gao, J., Liu, Y.-G., Zhou, Y., Boxer, L. M., Woolley, F. R., & Zingaro, R. A. (2007). Artificial zinc(II) complexes regulate cell cycle and apoptosis-related genes in tumor cell lines. CHEMBIOCHEM, 8(3), 332-340.

Role of the cyclic AMP response element in the bcl-2 promoter in the regulation of endogenous Bcl-2 expression and apoptosis in murine B cells
Xiang, H., Wang, J., & Boxer, L. M. (2006). Role of the cyclic AMP response element in the bcl-2 promoter in the regulation of endogenous Bcl-2 expression and apoptosis in murine B cells. MOLECULAR AND CELLULAR BIOLOGY, 26(22), 8599-8606.

Transcription factor gata4 regulates cardiac BCL2 gene expression in vitro and in vivo.
Kobayashi, S., Lackey, T., Huang, Y., Bisping, E., Pu, W. T., & Liang, Q. (2006). Transcription factor gata4 regulates cardiac BCL2 gene expression in vitro and in vivo. FASEB journal , 20(6), 800-802.

Transcription factor GATA4 regulates cardiac BCL2 gene expression in vitro and in vivo
Kobayashi, S., Lackey, T., Huang, Y., Bisping, E., Pu, W. T., & Liang, Q. (2006). Transcription factor GATA4 regulates cardiac BCL2 gene expression in vitro and in vivo. FASEB JOURNAL, 20(2), 800-?.

Oct transcription factors mediate t(14;18) lymphoma cell survival by directly regulating bcl-2 expression
Heckman, C. A., Duan, H., Garcia, P. B., & Boxer, L. M. (2006). Oct transcription factors mediate t(14;18) lymphoma cell survival by directly regulating bcl-2 expression. ONCOGENE, 25(6), 888-898.

C/EBP alpha and C/EBP alpha myeloid oncoproteins induce Bcl-2 via interaction of their basic regions with NF-kappa B p50.
Paz-Priel, I., Cai, D. H., Wang, D. H., Kowalski, J., Blackford, A., & Friedman, A. D. (2005). C/EBP alpha and C/EBP alpha myeloid oncoproteins induce Bcl-2 via interaction of their basic regions with NF-kappa B p50. BLOOD, 106(11), 838A-839A.

CCAAT/enhancer binding protein alpha (C/EBP alpha) and C/EBP alpha myeloid oncoproteins induce Bcl-2 via interaction of their basic regions with nuclear factor-kappa B p50
Paz-Priel, I., Cai, D. H., Wang, D. H., Kowalski, J., Blackford, A., & Friedman, A. D. (2005). CCAAT/enhancer binding protein alpha (C/EBP alpha) and C/EBP alpha myeloid oncoproteins induce Bcl-2 via interaction of their basic regions with nuclear factor-kappa B p50. MOLECULAR CANCER RESEARCH, 3(10), 585-596.

Regulatory elements in the immunoglobulin heavy chain gene 3 '-enhancers induce c-myc deregulation and lymphomagenesis in murine B cells
Wang, J. H., & Boxer, L. M. (2005). Regulatory elements in the immunoglobulin heavy chain gene 3 '-enhancers induce c-myc deregulation and lymphomagenesis in murine B cells. JOURNAL OF BIOLOGICAL CHEMISTRY, 280(13), 12766-12773.

Histone deacetylase inhibitors down-regulate bcl-2 expression and induce apoptosis in t(14;18) lymphomas
Duan, H., Heckman, C. A., & Boxer, L. M. (2005). Histone deacetylase inhibitors down-regulate bcl-2 expression and induce apoptosis in t(14;18) lymphomas. MOLECULAR AND CELLULAR BIOLOGY, 25(5), 1608-1619.

A genome-wide view of the in vitro response to L-asparaginase in acute lymphoblastic leukemia
Fine, B. M., Kaspers, G. Jl., Ho, M., Loonen, A. H., & Boxer, L. M. (2005). A genome-wide view of the in vitro response to L-asparaginase in acute lymphoblastic leukemia. CANCER RESEARCH, 65(1), 291-299.

C/EBP alpha and C/EBP alpha myeloid oncoproteins inhibit apoptosis and induce bcl-2 via DNA-binding dependent and independent mechanisms.
Paz-Priel, I., Cai, D. H., Wang, D. H., Heckman, C. A., Gombart, A. F., & Friedman, A. D. (2004). C/EBP alpha and C/EBP alpha myeloid oncoproteins inhibit apoptosis and induce bcl-2 via DNA-binding dependent and independent mechanisms. BLOOD, 104(11), 701A-702A.

Neurotrophin-3 and a CREB-mediated signaling pathway regulate Bcl-2 expression in oligodendrocyte progenitor cells
Saini, H. S., Gorse, K. M., Boxer, L. M., & Sato-Bigbee, C. (2004). Neurotrophin-3 and a CREB-mediated signaling pathway regulate Bcl-2 expression in oligodendrocyte progenitor cells. JOURNAL OF NEUROCHEMISTRY, 89(4), 951-961.

Gene expression patterns associated with recurrent chromosomal translocations in acute lymphoblastic leukemia
Fine, B. M., Stanulla, M., Schrappe, M., Ho, M., Viehmann, S., & Boxer, L. M. (2004). Gene expression patterns associated with recurrent chromosomal translocations in acute lymphoblastic leukemia. BLOOD, 103(3), 1043-1049.

Critical elements of the immunoglobulin heavy chain gene enhancers for deregulated expression of bcl-2
Heckman, C. A., Cao, T., Somsouk, L., Duan, H., Mehew, J. W., & Boxer, L. M. (2003). Critical elements of the immunoglobulin heavy chain gene enhancers for deregulated expression of bcl-2. CANCER RESEARCH, 63(20), 6666-6673.

Regulation of Bcl-2 expression by C/EBP in t(14;18) lymphoma cells
Heckman, C. A., Wheeler, M. A., & Boxer, L. M. (2003). Regulation of Bcl-2 expression by C/EBP in t(14;18) lymphoma cells. ONCOGENE, 22(39), 7891-7899.

Cytokine-mediated down-regulation of the transcription factor cAMP-response element-binding protein in pancreatic beta-cells
Jambal, P., Masterson, S., Nesterova, A., Bouchard, R., Bergman, B., & Pugazhenthi, S. (2003). Cytokine-mediated down-regulation of the transcription factor cAMP-response element-binding protein in pancreatic beta-cells. JOURNAL OF BIOLOGICAL CHEMISTRY, 278(25), 23055-23065.

Oxidative stress-mediated down-regulation of bcl-2 promoter in hippocampal neurons
Pugazhenthi, S., Nesterova, A., Jambal, P., Audesirk, G., Kern, M., & Reusch, J. Eb. (2003). Oxidative stress-mediated down-regulation of bcl-2 promoter in hippocampal neurons. JOURNAL OF NEUROCHEMISTRY, 84(5), 982-996.

Impaired proliferation and survival of activated B cells in transgenic mice that express a dominant-negative cAMP-response element-binding protein transcription factor in B cells
Zhang, C. Y., Wu, Y. L., & Boxer, L. M. (2002). Impaired proliferation and survival of activated B cells in transgenic mice that express a dominant-negative cAMP-response element-binding protein transcription factor in B cells. JOURNAL OF BIOLOGICAL CHEMISTRY, 277(50), 48359-48365.

In childhood acute lymphoblastic leukemia, BCR/ABL is associated with a more heterogeneous pattern of gene expression than is TEL/AML1 or MLL/AF4.
Fine, B. M., Stanulla, M., Schrappe, M., Ho, M. T., HARBOTT, J., & Boxer, L. M. (2002). In childhood acute lymphoblastic leukemia, BCR/ABL is associated with a more heterogeneous pattern of gene expression than is TEL/AML1 or MLL/AF4. BLOOD, 100(11), 753A-753A.

NF-kappa B activates Bcl-2 expression in t(14;18) lymphoma cells
Heckman, C. A., Mehew, J. W., & Boxer, L. M. (2002). NF-kappa B activates Bcl-2 expression in t(14;18) lymphoma cells. ONCOGENE, 21(24), 3898-3908.

A myc-associated zinc finger protein-related factor binding site is required for the deregulation of c-myc expression by the immunoglobulin heavy chain gene enhancers in Burkitt's lymphoma
Hu, H. M., Arcinas, M., & Boxer, L. M. (2002). A myc-associated zinc finger protein-related factor binding site is required for the deregulation of c-myc expression by the immunoglobulin heavy chain gene enhancers in Burkitt's lymphoma. JOURNAL OF BIOLOGICAL CHEMISTRY, 277(12), 9819-9824.

Allele-specific analysis of transcription factors binding to promoter regions
Heckman, C. A., & Boxer, L. M. (2002). Allele-specific analysis of transcription factors binding to promoter regions. METHODS, 26(1), 19-26.

The critical role of the PE21 element in oncostatin M-mediated transcriptional repression of the p53 tumor suppressor gene in breast cancer cells
Li, C., Ahlborn, T. E., Tokita, K., Boxer, L. M., Noda, A., & Liu, J. W. (2001). The critical role of the PE21 element in oncostatin M-mediated transcriptional repression of the p53 tumor suppressor gene in breast cancer cells. ONCOGENE, 20(57), 8193-8202.

The mechanism of bcl-2 activation by NF-kappa B in t(14;18) lymphomas.
Heckman, C. A., Mehew, J. W., & Boxer, L. M. (2001). The mechanism of bcl-2 activation by NF-kappa B in t(14;18) lymphomas. BLOOD, 98(11), 760A-760A.

Translocations involving c-myc and c-myc function
Boxer, L. M., & DANG, C. V. (2001). Translocations involving c-myc and c-myc function. ONCOGENE, 20(40), 5595-5610.

The cyclic AMP response element in the Bcl-2 promoter confers inducibility by hypoxia in neuronal cells
Freeland, K., Boxer, L. M., & Latchman, D. S. (2001). The cyclic AMP response element in the Bcl-2 promoter confers inducibility by hypoxia in neuronal cells. MOLECULAR BRAIN RESEARCH, 92(1-2), 98-106.

Molecular mechanisms of transcriptional control of bcl-2 and c-myc in follicular and transformed lymphoma
Arcinas, M., Heckman, C. A., Mehew, J. W., & Boxer, L. M. (2001). Molecular mechanisms of transcriptional control of bcl-2 and c-myc in follicular and transformed lymphoma. CANCER RESEARCH, 61(13), 5202-5206.

Suppression of apoptosis and granulocyte colony-stimulating factor-induced differentiation by an oncogenic form of Cbl
Sinha, S., Jancarik, J., Roginskaya, V., Rothermund, K., Boxer, L. M., & Corey, S. J. (2001). Suppression of apoptosis and granulocyte colony-stimulating factor-induced differentiation by an oncogenic form of Cbl. EXPERIMENTAL HEMATOLOGY, 29(6), 746-755.

Negative regulation of bcl-2 expression by p53 in hematopoietic cells
Wu, Y. L., Mehew, J. W., Heckman, C. A., Arcinas, M., & Boxer, L. M. (2001). Negative regulation of bcl-2 expression by p53 in hematopoietic cells. ONCOGENE, 20(2), 240-251.

Nerve growth factor- and epidermal growth factor-regulated gene transcription in PC12 pheochromocytoma and INS-1 insulinoma cells
Groot, M., Boxer, L. M., & Thiel, G. (2000). Nerve growth factor- and epidermal growth factor-regulated gene transcription in PC12 pheochromocytoma and INS-1 insulinoma cells. EUROPEAN JOURNAL OF CELL BIOLOGY, 79(12), 924-935.

Regulation of Bcl-2 expression by NF-kappa B in t(14;18) lymphoma cells.
Heckman, C. A., Mehew, J. W., & Boxer, L. M. (2000). Regulation of Bcl-2 expression by NF-kappa B in t(14;18) lymphoma cells. BLOOD, 96(11), 299A-299A.

NF-kappa B activity is required for the deregulation of c-myc expression by the immunoglobulin heavy chain enhancer
Kanda, K., Hu, H. M., Zhang, L., Grandchamps, J., & Boxer, L. M. (2000). NF-kappa B activity is required for the deregulation of c-myc expression by the immunoglobulin heavy chain enhancer. JOURNAL OF BIOLOGICAL CHEMISTRY, 275(41), 32338-32346.

Akt/protein kinase B up-regulates Bcl-2 expression through cAMP-response element-binding protein
Pugazhenthi, S., Nesterova, A., Sable, C., Heidenreich, K. A., Boxer, L. M., & Reusch, J. Eb. (2000). Akt/protein kinase B up-regulates Bcl-2 expression through cAMP-response element-binding protein. JOURNAL OF BIOLOGICAL CHEMISTRY, 275(15), 10761-10766.

A-Myb up-regulates bcl-2 through a Cdx binding site in t(14;18) lymphoma cells
Heckman, C. A., Mehew, J. W., Ying, G. G., Introna, M., Golay, J., & Boxer, L. M. (2000). A-Myb up-regulates bcl-2 through a Cdx binding site in t(14;18) lymphoma cells. JOURNAL OF BIOLOGICAL CHEMISTRY, 275(9), 6499-6508.

The expression of p53 tumor suppressor gene in breast cancer cells is down-regulated by cytokine oncostatin M
Liu, J. W., Li, C., Ahlborn, T. E., Spence, M. J., Meng, L., & Boxer, L. M. (1999). The expression of p53 tumor suppressor gene in breast cancer cells is down-regulated by cytokine oncostatin M. CELL GROWTH & DIFFERENTIATION, 10(10), 677-683.

Insulin-like growth factor-I induces bcl-2 promoter through the transcription factor cAMP-response element-binding protein
Pugazhenthi, S., Millers, E., Sable, C., Young, P., Heidenreich, K. A., & Reusch, J. Eb. (1999). Insulin-like growth factor-I induces bcl-2 promoter through the transcription factor cAMP-response element-binding protein. JOURNAL OF BIOLOGICAL CHEMISTRY, 274(39), 27529-27535.

A zinc-finger transcription factor induced by TGF-beta promotes apoptotic cell death in epithelial Mv1Lu cells
Chalaux, E., Lopez-Rovira, T., Rosa, J. L., Pons, G., Boxer, L. M., & Ventura, F. (1999). A zinc-finger transcription factor induced by TGF-beta promotes apoptotic cell death in epithelial Mv1Lu cells. FEBS LETTERS, 457(3), 478-482.

p53 suppresses the activation of the Bcl-2 promoter by the Brn-3a POU family transcription factor
Budhram-Mahadeo, V., Morris, P. J., Smith, M. D., Midgley, C. A., Boxer, L. M., & Latchman, D. S. (1999). p53 suppresses the activation of the Bcl-2 promoter by the Brn-3a POU family transcription factor. JOURNAL OF BIOLOGICAL CHEMISTRY, 274(21), 15237-15244.

Activation of the Bcl-2 promoter by nerve growth factor is mediated by the p42/p44 MAPK cascade
Liu, Y. Z., Boxer, L. M., & Latchman, D. S. (1999). Activation of the Bcl-2 promoter by nerve growth factor is mediated by the p42/p44 MAPK cascade. NUCLEIC ACIDS RESEARCH, 27(10), 2086-2090.

An NF-kappa B site in the IgH enhancer deregulates bcl-2 expression in t(14;18) lymphomas.
Somsouk, L., Heckman, C. A., Mehew, J. W., Kanda, K., & Boxer, L. M. (1999). An NF-kappa B site in the IgH enhancer deregulates bcl-2 expression in t(14;18) lymphomas. FASEB JOURNAL, 13(7), A1465-A1465.

An NF-kappa B site in the IgH enhancer deregulates c-myc expression in Burkitt's lymphoma.
Kanda, K., Grandchamps, J., & Boxer, L. M. (1998). An NF-kappa B site in the IgH enhancer deregulates c-myc expression in Burkitt's lymphoma. BLOOD, 92(10), 382A-382A.

The N-terminal domain unique to the long form of the Brn-3a transcription factor is essential to protect neuronal cells from apoptosis and for the activation of Bcl-2 gene expression
Smith, M. D., DAWSON, S. J., Boxer, L. M., & Latchman, D. S. (1998). The N-terminal domain unique to the long form of the Brn-3a transcription factor is essential to protect neuronal cells from apoptosis and for the activation of Bcl-2 gene expression. NUCLEIC ACIDS RESEARCH, 26(18), 4100-4107.

Bcl-2 transcription from the proximal P2 promoter is activated in neuronal cells by the Brn-3a POU family transcription factor
Smith, M. D., Ensor, E. A., Coffin, R. S., Boxer, L. M., & Latchman, D. S. (1998). Bcl-2 transcription from the proximal P2 promoter is activated in neuronal cells by the Brn-3a POU family transcription factor. JOURNAL OF BIOLOGICAL CHEMISTRY, 273(27), 16715-16722.

The WT1 protein is a negative regulator of the normal bcl-2 allele in t(14;18) lymphomas
Heckman, C., Mochon, E., Arcinas, M., & Boxer, L. M. (1997). The WT1 protein is a negative regulator of the normal bcl-2 allele in t(14;18) lymphomas. JOURNAL OF BIOLOGICAL CHEMISTRY, 272(31), 19609-19614.

Identification of the major positive regulators of c-myb expression in hematopoietic cells of different lineages
Sullivan, J., Feeley, B., GUERRA, J., & Boxer, L. M. (1997). Identification of the major positive regulators of c-myb expression in hematopoietic cells of different lineages. JOURNAL OF BIOLOGICAL CHEMISTRY, 272(3), 1943-1949.

Induction of bcl-2 expression by phosphorylated CREB proteins during B-cell activation and rescue from apoptosis
Wilson, B. E., Mochon, E., & Boxer, L. M. (1996). Induction of bcl-2 expression by phosphorylated CREB proteins during B-cell activation and rescue from apoptosis. MOLECULAR AND CELLULAR BIOLOGY, 16(10), 5546-5556.

CREB proteins function as positive regulators of the translocated bcl-2 allele in t(14;18) lymphomas
Ji, L., Mochon, E., Arcinas, M., & Boxer, L. M. (1996). CREB proteins function as positive regulators of the translocated bcl-2 allele in t(14;18) lymphomas. JOURNAL OF BIOLOGICAL CHEMISTRY, 271(37), 22687-22691.

Identification of an inducible regulator of c-myb expression during T-cell activation
Phan, S. C., Feeley, B., Withers, D., & Boxer, L. M. (1996). Identification of an inducible regulator of c-myb expression during T-cell activation. MOLECULAR AND CELLULAR BIOLOGY, 16(5), 2387-2393.

REPRESSION OF THE C-MYB GENE BY WT1 PROTEIN IN T-CELL AND B-CELL LINES
McCann, S., Sullivan, J., GUERRA, J., Arcinas, M., & Boxer, L. M. (1995). REPRESSION OF THE C-MYB GENE BY WT1 PROTEIN IN T-CELL AND B-CELL LINES. JOURNAL OF BIOLOGICAL CHEMISTRY, 270(40), 23785-23789.

MYB BINDING-SITES MEDIATE NEGATIVE REGULATION OF C-MYB EXPRESSION IN T-CELL LINES
GUERRA, J., Withers, D. A., & Boxer, L. M. (1995). MYB BINDING-SITES MEDIATE NEGATIVE REGULATION OF C-MYB EXPRESSION IN T-CELL LINES. BLOOD, 86(5), 1873-1880.

PI-1 BINDING-SITES ARE NEGATIVE REGULATORS OF BCL-2 EXPRESSION IN PRE-B CELLS
Chen, H. M., & Boxer, L. M. (1995). PI-1 BINDING-SITES ARE NEGATIVE REGULATORS OF BCL-2 EXPRESSION IN PRE-B CELLS. MOLECULAR AND CELLULAR BIOLOGY, 15(7), 3840-3847.

THE TRANSCRIPTION FACTOR, NM23H2, BINDS TO AND ACTIVATES THE TRANSLOCATED C-MYC ALLELE IN BURKITTS-LYMPHOMA
Ji, L., Arcinas, M., & Boxer, L. M. (1995). THE TRANSCRIPTION FACTOR, NM23H2, BINDS TO AND ACTIVATES THE TRANSLOCATED C-MYC ALLELE IN BURKITTS-LYMPHOMA. JOURNAL OF BIOLOGICAL CHEMISTRY, 270(22), 13392-13398.

NF-KAPPA-B SITES FUNCTION AS POSITIVE REGULATORS OF EXPRESSION OF THE TRANSLOCATED C-MYC ALLELE IN BURKITTS-LYMPHOMA
Ji, L., Arcinas, M., & Boxer, L. M. (1994). NF-KAPPA-B SITES FUNCTION AS POSITIVE REGULATORS OF EXPRESSION OF THE TRANSLOCATED C-MYC ALLELE IN BURKITTS-LYMPHOMA. MOLECULAR AND CELLULAR BIOLOGY, 14(12), 7967-7974.

NF-KAPPA-B SITES FUNCTION AS POSITIVE REGULATORS OF EXPRESSION OF THE TRANSLOCATED C-MYC ALLELE IN BURKITTS-LYMPHOMA
Ji, L., Arcinas, M., & Boxer, L. M. (1994). NF-KAPPA-B SITES FUNCTION AS POSITIVE REGULATORS OF EXPRESSION OF THE TRANSLOCATED C-MYC ALLELE IN BURKITTS-LYMPHOMA. BLOOD, 84(10), A37-A37.

DIFFERENTIAL PROTEIN-BINDING TO THE C-MYC PROMOTER DURING DIFFERENTIATION OF HEMATOPOIETIC-CELL LINES
Arcinas, M., & Boxer, L. M. (1994). DIFFERENTIAL PROTEIN-BINDING TO THE C-MYC PROMOTER DURING DIFFERENTIATION OF HEMATOPOIETIC-CELL LINES. ONCOGENE, 9(9), 2699-2706.

ACTIVATION OF C-MYC EXPRESSION BY C-ABL IS INDEPENDENT OF BOTH THE DNA-BINDING FUNCTION OF C-ABL AND THE C-MYC EP SITE
Arcinas, M., Sizer, K. C., & Boxer, L. M. (1994). ACTIVATION OF C-MYC EXPRESSION BY C-ABL IS INDEPENDENT OF BOTH THE DNA-BINDING FUNCTION OF C-ABL AND THE C-MYC EP SITE. JOURNAL OF BIOLOGICAL CHEMISTRY, 269(34), 21919-21924.

THE ROLE OF ONCOGENES IN HEMATOLOGIC MALIGNANCIES
Boxer, L. M. (1994). THE ROLE OF ONCOGENES IN HEMATOLOGIC MALIGNANCIES. ANNUAL REVIEW OF MEDICINE, 45, 1-11.